相关实验视频
Updated: Aug 14, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.9K
持久的左心室辅助装置植入一个患有阳性A型大动脉解剖患者的患者
Dominik Geiger1, Gaik Nersesian2, Leonard Pitts2
1Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.
JACC. Case reports
|December 10, 2025
概括
在患有阳性A型大动脉解剖 (iTAAD) 和心脏性休克的患者中,采用机械循环支持 (MCS) 的保守方法可以安全地弥合长期左心室辅助装置植入.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 主动脉疾病 主动脉疾病
背景情况:
- 带有心脏性休克的急性心肌梗塞需要机械循环支持 (MCS).
- 在干预后可以发生Iatrogenic类型A大动脉剖析 (iTAAD).
- 在心肌梗塞的背景下,iTAAD的管理是复杂的.
研究的目的:
- 报告通过皮肤冠状动脉干预失败后患有亚原性A型大动脉剖析的患者的复杂管理.
- 讨论心脏性休克中iTAAD的保守管理策略.
主要方法:
- 使用Impella装置进行初始稳定.
- 由于并发症而升级到高级的MCS.
- 稳定的iTAAD的保守管理,没有 perfusion.
- 由于持续的左心室功能障碍,植入持久的左心室辅助装置.
主要成果:
- 最初的MCS稳定因血管损伤和血液动力学不稳定性而复杂.
- 在保守的管理下,iTAAD保持稳定,没有系统性恶化.
- 持续严重的左心室功能障碍需要持久的MCS.
结论:
- 亚热性A型大动脉剖析 (iTAADs) 与自发剖析不同,由过程性损伤引起.
- 尽管缺乏正式指导方针,但对稳定的iTAAD的保守管理可能是安全的.
- 通过MCS的"警等待"策略,可以安全地将心脏性休克的选定iTAAD患者与持久的左心室辅助器件植入相连接.
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

